– USA, CA – VisiQuate, a leading provider of business analytics solutions, announced that it has received a significant contribution to its $6M+ Series C round from First Analysis, a Chicago-based leading private growth-equity investor. According to founder and CEO Brian Robertson, this is the latest in a series of exciting developments for the Santa Rosa-based company, which serves clients across the country in healthcare, energy and other large business verticals.
“When we founded the company in 2009,” Robertson explained, “we saw the potential for true business analytics to transform the way decisions are made, not just by analysts and the C-suite, but at every level of the enterprise where current, streaming intelligence can help decision and knowledge workers improve productivity and achieve advanced operating results.”
Robertson further explained that VisiQuate solutions are at least a generation beyond traditional analytics that are based on static dashboards and lagging indicators. In their most recent platform release, they feature streaming intelligence solutions that combines predictive analytics, leading and root-case insights, and exception-based visualizations that are designed to dramatically accelerate and improve what they often refer to as the “decision meets action” equation.
Robertson added, “We are very excited and honored by the participation of First Analysis as a major investor and with the addition of Howard Smith to our Board of Directors. We are planning to direct proceeds from the financing towards continued product innovations and enhancements, including further advancing our operational BI and workflow solutions as well as increased business development and client services talent.
First Analysis Managing Director Howard Smith is enthused about the company’s momentum. “VisiQuate offers a unique and compelling end-to-end analytics platform that has been deployed by leading organizations in industries such as healthcare and energy that face complex and large-scale data challenges,” Smith said. “We’re excited about the opportunity to work with the VisiQuate team to realize the company’s enormous potential.”
Howard Smith will serve as the newest member of VisiQuate’s board of directors.
Founded in 2009, VisiQuate delivers performance management solutions via SaaS that transform decision-making throughout the enterprise, putting the capabilities of Business Analytics to work, not just for analysts and top management, but for line workers. VisiQuate goes beyond traditional Business Analytics, and gives its clients actionable workflows, guided eLearning solutions, and a rich complement of industry domain experts who help them achieve the best performance outcomes. Headquartered in Santa Rosa, CA, with offices across the country and in Europe, VisiQuate currently serves clients in healthcare, energy, financial services, and other industries. For more information, visit www.visiquate.com.
About First Analysis
First Analysis has one of the longest records (29 years) in private capital investing and has invested more than $700 million across 12 funds in three fund families. First Analysis invests in high-growth sectors where its expertise and differentiated research approach drive success: health care, IT applications and outsourced services, and clean-tech / chemicals. First Analysis helps established companies become profitable leaders in large markets, funding growth plans and working closely with management in areas including strategy, recruitment, sales and marketing, and corporate development. Its flexible approach targets investing $3-10 million as lead investor, or as a syndicate partner who brings valuable perspective to the table.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.